New imaging agent spots hidden breast cancer spread
NCT ID NCT04758780
First seen Jan 11, 2026 · Last updated May 16, 2026 · Updated 20 times
Summary
This study tested a new radioactive tracer called 89Zr-TLX250 that attaches to a protein (CAIX) found on some triple negative breast cancer cells. Twelve people with advanced triple negative breast cancer received the tracer and had a PET/CT scan. The researchers compared how many tumors the new scan found versus the standard FDG PET/CT scan, especially in the brain, bones, and other organs. The goal was to see if this new method could find more cancer spots and help doctors better understand the spread of the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRIPLE-NEGATIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ICO René Gauducheau
Saint-Herblain, 44805, France
Conditions
Explore the condition pages connected to this study.